Jingchuan Zhang

Articles by Jingchuan Zhang

9 Real-world Treatment Patterns and Clinical Outcomes in Patients Treated With Eribulin After Prior Immunotherapy (IO) or Antibody-Drug Conjugate (ADC) for Metastatic Breast Cancer

ByRavi K. Goyal,Jingchuan Zhang,Samina Dhuliawala,Martina Sluga-O’Callaghan,Peter A. Kaufman, MD

April 18th 2022

Latest Updated Articles

9 Real-world Treatment Patterns and Clinical Outcomes in Patients Treated With Eribulin After Prior Immunotherapy (IO) or Antibody-Drug Conjugate (ADC) for Metastatic Breast Cancer
April 18th 2022

Trending on CancerNetwork

Pasritamig Plus JNJ-9401 Yields 73% PSA Response in Metastatic CRPC

Nogapendekin Alfa/BCG Earns Israeli Approval in BCG-Unresponsive NMIBC

PIKTOR Plus Paclitaxel Yields Responses in Pretreated PAM-Mutated Endometrial Cancer

Managing Dermatologic Toxicity and Holding Therapy

Cesalatamig Monotherapy Yields Responses in PD-(L)1–Resistant NSCLC